Tandem Diabetes appoints Sandra Beaver to board, adds audit and cybersecurity roles

TANDEM DIABETES CARE INC

Sandra Beaver joined the board effective Nov. 7, 2025, increasing board size from 8 to 9.
She serves on the Audit and Cybersecurity & Data Privacy committees.
Initial RSU award of 20,242 shares valued at $300K; annual retainer $60K plus committee fees.
Beaver is CFO of Lyra Health; previously CFO of Evolus and held finance roles at Experian and IGT.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.